CardioDynamics Sells Vermed Business for $8M


June 27, 2007

June 22, 2007 - CardioDynamics, an impedance cardiography (ICG) technology developer, announced that it has reached an agreement to sell its Vermed unit to the subsidiary's management team for a cash purchase price of $8 million, allowing CardioDynamics to focus its resources on its proprietary ICG business, which continues to hold the highest growth potential.

The company will maintain a long-term preferential relationship with Vermed for ICG sensors. As a condition of closing, CardioDynamics will enter into a five-year fixed price supplier agreement with Vermed for the proprietary ICG sensors.

The sale is expected to close in the latter part of the company's fiscal third quarter ending Aug. 31, 2007.

For more information:

The content of this field is kept private and will not be shown publicly.
Type the characters you see in this picture. (verify using audio)
Type the characters you see in the picture above; if you can't read them, submit the form and a new image will be generated. Not case sensitive.